118 related articles for article (PubMed ID: 38456715)
21. Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan.
Uda K; Okubo Y; Tsuge M; Tsukahara H; Miyairi I
Vaccine; 2023 Jul; 41(34):4958-4966. PubMed ID: 37400282
[TBL] [Abstract][Full Text] [Related]
22. Validation of health economic models: the example of EVITA.
Hammerschmidt T; Goertz A; Wagenpfeil S; Neiss A; Wutzler P; Banz K
Value Health; 2003; 6(5):551-9. PubMed ID: 14627061
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster.
Littlewood KJ; Ouwens MJ; Sauboin C; Tehard B; Alain S; Denis F
Clin Ther; 2015 Apr; 37(4):830-841.e7. PubMed ID: 25721380
[TBL] [Abstract][Full Text] [Related]
24. Varicella paediatric hospitalisations in Belgium: a 1-year national survey.
Blumental S; Sabbe M; Lepage P;
Arch Dis Child; 2016 Jan; 101(1):16-22. PubMed ID: 26130380
[TBL] [Abstract][Full Text] [Related]
25. [Varicella complications: is it time to consider a routine varicella vaccination?].
Dulović O; Gvozdenović E; Nikolić J; Spurnić AR; Katanić N; Kovarević-Pavićević D
Vojnosanit Pregl; 2010 Jul; 67(7):523-9. PubMed ID: 20707045
[TBL] [Abstract][Full Text] [Related]
26. The burden of varicella in Germany. Potential risks and economic impact.
Banz K; Wagenpfeil S; Neiss A; Hammerschmidt T; Wutzler P
Eur J Health Econ; 2004 Feb; 5(1):46-53. PubMed ID: 15452764
[TBL] [Abstract][Full Text] [Related]
27. Cost effectiveness and budget impact of universal varicella vaccination in Russia.
Marijam A; Safonova E; Scherbakov M; Shpeer E; Van Oorschot D; Rudakova A; Tatochenko V; Briko N
Hum Vaccin Immunother; 2022 Nov; 18(5):2045152. PubMed ID: 35258445
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian Sentinel Group on Pediatric Infectious Diseases.
Fornaro P; Gandini F; Marin M; Pedrazzi C; Piccoli P; Tognetti D; Assael BM; Lucioni C; Mazzi S
Pediatr Infect Dis J; 1999 May; 18(5):414-9. PubMed ID: 10353513
[TBL] [Abstract][Full Text] [Related]
29. Early-Life Antibiotic Exposure Associated With Varicella Occurrence and Breakthrough Infections: Evidence From Nationwide Pre-Vaccination and Post-Vaccination Cohorts.
Lin TL; Fan YH; Chang YL; Ho HJ; Liang LL; Chen YJ; Wu CY
Front Immunol; 2022; 13():848835. PubMed ID: 35432330
[TBL] [Abstract][Full Text] [Related]
30. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
[TBL] [Abstract][Full Text] [Related]
31. Varicella in pediatric liver transplant patients: a retrospective analysis of treatment and outcome.
Pacini-Edelstein SJ; Mehra M; Ament ME; Vargas JH; Martin MG; McDiarmid SV
J Pediatr Gastroenterol Nutr; 2003 Aug; 37(2):183-6. PubMed ID: 12883306
[TBL] [Abstract][Full Text] [Related]
32. VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention.
McKendrick MW; Lau J; Alston S; Bremner J
J Infect; 2007 Jul; 55(1):64-7. PubMed ID: 17418420
[TBL] [Abstract][Full Text] [Related]
33. The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France.
Coudeville L; Paree F; Lebrun T; Sailly J
Vaccine; 1999 Jan; 17(2):142-51. PubMed ID: 9987148
[TBL] [Abstract][Full Text] [Related]
34. [Hospital admissions for varicella complications in children aged less than 15 years old].
Pérez-Yarza EG; Arranz L; Alustiza J; Azkunaga B; Uriz J; Sarasua A; Mendiburu I; Emparanza JI;
An Pediatr (Barc); 2003 Sep; 59(3):229-33. PubMed ID: 12975114
[TBL] [Abstract][Full Text] [Related]
35. The epidemiology and economic impact of varicella-related hospitalizations in Turkey from 2008 to 2010: a nationwide survey during the pre-vaccine era (VARICOMP study).
Dinleyici EC; Kurugol Z; Turel O; Hatipoglu N; Devrim I; Agin H; Gunay I; Yasa O; Erguven M; Bayram N; Kizildemir A; Alhan E; Kocabas E; Tezer H; Aykan HH; Dalgic N; Kilic B; Sensoy G; Belet N; Kulcu NU; Say A; Tas MA; Ciftci E; Ince E; Ozdemir H; Emiroglu M; Odabas D; Yargic ZA; Nuhoglu C; Carman KB; Celebi S; Hacimustafaoglu M; Elevli M; Ekici Z; Celik U; Kondolot M; Ozturk M; Tapisiz A; Ozen M; Tepeli H; Parlakay A; Kara A; Somer A; Caliskan B; Velipasalioglu S; Oncel S; Arisoy ES; Guler E; Dalkiran T; Aygun D; Akarsu S;
Eur J Pediatr; 2012 May; 171(5):817-25. PubMed ID: 22170238
[TBL] [Abstract][Full Text] [Related]
36. Decline of Neurologic Varicella Complications in Children During the First Seven Years After Introduction of Universal Varicella Vaccination in Germany, 2005-2011.
Streng A; Grote V; Rack-Hoch A; Liese JG
Pediatr Infect Dis J; 2017 Jan; 36(1):79-86. PubMed ID: 27749651
[TBL] [Abstract][Full Text] [Related]
37. [Hospital admissions due to varicella in a tertiary hospital].
Guzmán Laura KP; Periañez Vasco A; Falcón Neyra MD; Croche Santander B
An Pediatr (Barc); 2014 Jun; 80(6):399-403. PubMed ID: 24286883
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluation of varicella vaccination in Swiss children and adolescents.
Banz K; Iseli A; Aebi C; Brunner M; Schmutz AM; Heininger U
Hum Vaccin; 2009 Dec; 5(12):847-57. PubMed ID: 19829048
[TBL] [Abstract][Full Text] [Related]
39. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
[TBL] [Abstract][Full Text] [Related]
40. Recognition & management of varicella infections and accuracy of antimicrobial recommendations: Case vignettes study in the US.
Fergie J; Pawaskar M; Veeranki P; Samant S; Harley C; MacEwan J; Schwartz TT; Surati S; Conway JH
PLoS One; 2022; 17(6):e0269596. PubMed ID: 35749342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
